explore -WSS

explore

author：focus 2025-09-30 18:59:51 - browse：72

SAN DIEGO — After starting off the year with lower revenue projections than market analysts had hoped for, San Diego-based genomics giant Illumina lowered expectations again on Wednesday, forecasting annual growth of 1% compared to the previous year.

The market’s response was swift. Minutes after the company issued its press release, shares in Illumina dipped from $184.49 to below $172 during after-hours trading.

In its release, Illumina noted that it expects revenue from the company’s core business to be essentially the same this year compared to last, and that it expects revenue from Grail, the cancer diagnostics company that Illumina acquired for $8 billion in the fall of 2021, to remain in the range of $90 and $100 million.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： ASCO Daily Recap: CAR

WSS

Eli Lilly’s Zepbound improved liver scarring in mid

How CO2 helps viruses stay alive longer in the air

Caitlin Bernard's story shows physicians can't shy from advocacy

Review: 'Barbie' will hit you like a shot in the heart

Death toll from an explosion and collapse of a Paris building in June climbs to 3

What to know about Saharan dust affecting the US and how it can affect health

focus

explore

focus

BioMarin wins approval for gene therapy to treat hemophilia A

A new initiative will help leaders fight the next pandemic

Trump demands the U.S. pay no more for drugs than other countries … again

Marvel Studios reveals new trailer for 'The Marvels': Watch here

After affirmative action ruling, medical educators look to 'holistic review'

White House launches permanent pandemic office

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

How CO2 helps viruses stay alive longer in the air

Apple is now the first public company to be valued at $3 trillion

Structure Therapeutics oral GLP

Wikipedia

In new study, freeze

As Taiwan prepares for anti

Senators tussle over abortion against the backdrop of a presidential campaign

Organ transplantation is at a crossroads. Major reform is needed

Finland to offer bird flu vaccine to select groups of people, a possible global first

FTC loses bid to block Novant's North Carolina hospital merger

focus

explore

focus

explore